… The actions of pro-atherogenic cytokines can be better appreciated based on experimental
studies with hyperlipidaemic mouse models. For example, TNF-α −/− , apolipoprotein E (ApoE…

… of atherosclerotic mouse models have greatly improved our understanding of the role of
cytokines and … Normally wild-type mice do not develop atherosclerosis, however, ApoE knockout …

… the microbiota and cytokines changed together in the process of mice with atherosclerosis.
… mechanisms involved in the process of atherosclerosis. These results imply the dysbiosis …

… established the role of inflammatory cytokines in coronary artery disease, … cytokine-targeted
treatment approaches have emerged as potential tools in the management of atherosclerotic …

… the cytokine in the atherosclerosis lesions. IL10 delivered by NC was bioactive and reduced
the production of pro-inflammatory cytokine … cytokine delivery for preventing atherosclerotic …

… The majority of T cells in mouse and human atherosclerotic plaques … cytokines, CD4+ T
lymphocytes differentiate into a Th1, Th2 or Th17 lineage. Besides producing specific cytokines …

… Genetic or pharmacological studies in mice … cytokines have been shown to regulate
atherosclerosis [2], here we focus on cytokines which have an established role in atherosclerosis …

… of inflammatory cytokines in the development of atherosclerotic … It is shown in studies in
various animal models of atherosclerosis … in atherosclerotic lesions in ApoE-deficient mice with …

… cytokine and appears in atherosclerotic lesions triggered by multiple modified LDL [48]. In the
ApoE–/– mouse … in ApoE–/– mice resulted in significant 60% atherosclerosis lowering. It is …

… , a primary inflammatory cytokine in progressive atherosclerosis, … Here, we discuss the
pro-atherosclerotic implication of this … an example where treatment of pregnant mice with 1-methyl-…